Literature DB >> 1733367

Effect of sepsis or cytokine administration on release of gut peptides.

O Zamir1, P O Hasselgren, T Higashiguchi, J A Frederick, J E Fischer.   

Abstract

The effect of sepsis on plasma levels of various gut peptides was studied in rats. Sepsis was induced by cecal ligation and puncture (CLP); control animals underwent sham operation. Sixteen hours after CLP or sham operation, portal and systemic blood was drawn, and plasma levels of gastrin, vasoactive intestinal peptide (VIP), secretin, peptide YY (PYY), gastrin-releasing peptide (GRP), and substance P were determined by radioimmunoassay. Plasma levels of gastrin, VIP, PYY, and secretin were elevated in septic rats compared with nonseptic animals, with the highest levels noted in portal blood. There was no effect of sepsis on GRP or substance P levels. In other experiments, human recombinant interleukin 1 alpha (IL-1 alpha) or recombinant tumor necrosis factor alpha (TNF alpha) was injected intraperitoneally (300 micrograms/kg body weight in 3 divided doses over 16 hours). There was no change in plasma levels of gut peptides after IL-1 alpha injection. TNF alpha induced elevation of PYY levels in portal plasma with no change in other gut peptide levels. The results suggest that sepsis stimulates release of certain gut peptides and that TNF, but not IL-1, may be partly responsible for this response. The mechanism of the release of gut peptides and its significance in the pathophysiologic changes induced by sepsis remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733367     DOI: 10.1016/0002-9610(92)90273-t

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

Review 1.  Bench-to-bedside review: the gut as an endocrine organ in the critically ill.

Authors:  Adam Deane; Marianne J Chapman; Robert J L Fraser; Michael Horowitz
Journal:  Crit Care       Date:  2010-09-24       Impact factor: 9.097

Review 2.  Ischemia-reperfusion injury of the intestine and protective strategies against injury.

Authors:  Ismail Hameed Mallick; Wenxuan Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 3.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

4.  Increased intestinal protein synthesis during sepsis and following the administration of tumour necrosis factor alpha or interleukin-1 alpha.

Authors:  D von Allmen; P O Hasselgren; T Higashiguchi; J Frederick; O Zamir; J E Fischer
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

5.  Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells.

Authors:  Jinxiang Yuan; Xiaoqiu Liu; Allen W Wu; Patrick W McGonagill; Michael J Keller; Courtney S Galle; Jeffery L Meier
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

6.  Serum transferrin as a prognostic indicator of spontaneous closure and mortality in gastrointestinal cutaneous fistulas.

Authors:  B W Kuvshinoff; R J Brodish; D W McFadden; J E Fischer
Journal:  Ann Surg       Date:  1993-06       Impact factor: 12.969

7.  Prolonged lipopolysaccharide-induced illness elevates glucagon-like peptide-1 and suppresses peptide YY: A human-randomized cross-over trial.

Authors:  Katrine Brodersen; Maike Mose; Ulla Ramer Mikkelsen; Jens Otto Lunde Jørgensen; Michael Festersen Nielsen; Niels Møller; Anne-Marie Wegeberg; Christina Brock; Bolette Hartmann; Jens Juul Holst; Nikolaj Rittig
Journal:  Physiol Rep       Date:  2022-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.